Supplementary Figure S5: Ipilimumab increases the frequency of CD3+CD8+ T cells but not CD3-CD8+CD56+ NK cells in human melanoma from Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3&lt;sup&gt;+&lt;/sup&gt; Regulatory T Cells (Tregs) in Human Cancers